Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver disease

US Patent 8389472 · Granted Mar 5, 2013

Estimated economic value: $3,955,000

Assignee

Inventors

View full patent text on Google Patents →